EXPERIENCE OF THE EFFICIENT USING OF METHOTREXATE FOR SUBCUTANEOUS ADMINISTRATION IN PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
https://doi.org/10.15690/vsp.v13i4.1101
Abstract
About the Authors
S. A. UshakovaRussian Federation
Ushakova Svetlana Anatol’evna, MD, associate professor of Pediatric Department of Advanced Training and Retraing of Medical Specialists Faculty
O. V. Pavlova
Russian Federation
O. Yu. Khalidullina
Russian Federation
V. N. Lukyanova
Russian Federation
References
1. Alexeeva E. I., Litvitskii P. F. Yuvenil’nyi revmatoidnyi artrit: etiologiya, patogenez, klinika, algoritmy diagnostiki i lecheniya: Ruk-vo dlya vrachei, prepodavatelei, nauch. sotr. Pod obshch. red. A. A. Baranova [Juvenile Rheumatoid Arthritis: Etiology, Pathogenesis, Clinical Algorithms for Diagnosis and Treatment: Guideline for Doctors, Tutors, Research Scientists. Edited by A. A. Baranov]. Moscow, VEDI, 2007. 368 p.
2. Ruk-vo po detskoi revmatologii. Pod red. N. A. Geppe, N. S. Podchernyaevoi, G. A. Lyskinoi [Guideline in Pediatric Rheumatology. Edited by N. A. Geppe, N. S. Podchernyaeva, G. A. Lyskina]. Moscow, GEOTAR-Media, 2011. 720 p.
3. Rodionovskaya S. R., Nikishina I. P. Nauch.-prakt. revmatol. — Science-practical rheumatology. 2003; 2: 65–71.
4. Alekseeva E. I., Valieva S. I., Bzarova T. M., Denisova R. V. Vopr. sovr. pediatrii — Current pediatrics. 2011; 10 (1): 42–49.
5. Giannini E. H., Brewer E. J., Kuzmina N., Shaikov A., Maximov A., Vorontsov I., Fink C. W., Newman A. J., Cassidy J. T., Zemel L. S. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A. — U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N. Engl. J. Med. 1992; 12 (16): 1043–1049.
6. Baranov A. A., Alexeeva E. I., Bzarova T. M., Valieva S. I., Deni sova R. V., Isaeva K. B., Karagulyan N. A., Litvitskii P. F., Mitenko E. V., Sleptsova T. V., Fetisova A. N., Chistyakova E. G., Taibulatov N. I., Morev S.Yu. Vopr. sovr. pediatrii — Current pediatrics. 2013; 12 (1): 37–56.
7. Beukelman T., Patkar N. M., Saag K. G., Tolleson-Rinehart S., Cron R. Q., DeWitt E. M., Ilowite N. T., Kimura Y., Laxer R. M., Lovell D. J. American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. (Hoboken). 2011; 12 (4): 465–482.
8. Dueckers G., Guellac N., Arbogast M. Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis. Clin. Immunol. 2012; 142: 176–193.
9. Nikishina I. P., Kuz'mina N. N. Vestnik RAMN — Annals of the Russian Academy of Medical Sciences. 2008; 6: 41–48.
10. Beukelman T., Ringold S., Davis T. E., DeWitt E. M., Pelajo C. F., Weiss P. F., Kimura Y. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J. Rheumatol. 2012; 12 (9): 1867–1874.
11. Yaremenko O. B. Ukrains’kii Revmatologichnyi zhurn. — Ukrainsky Revmatologichny journal. 2002; 3 (9): 45–51.
12. Alekseeva E. I., Sleptsova T. V., Valieva S. I., Bzarova T. M., Denisova R. V., Isaeva K. B., Mitenko E. V., Chistyakova E. G., Fetisova A. N., Taibulatov N. I. Vopr. sovr. pediatrii — Current pediatrics. 2013; 12 (4): 38–46.
13. Ruperto N., Murray K. J., Gerloni V., Wulffraat N., de Oliveira S. K., Falcini F., Dolezalova P., Alessio M., Burgos-Vargas R., Corona F., Vesely R., Foster H., Davidson J., Zulian F., Asplin L., Baildam E., Consuegra J. G., Ozdogan H., Saurenmann R., Joos R., Pistorio A., Woo P., Martini A. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. 2004; 12 (7): 2191–2201.
14. Tukova J., Chladek J., Nemcova D., Chladkova J., Dolezalova P. Methotrexate bioavailability after oral and subcutaneous administration in children with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 2009; 12 (6): 1047–1053.
15. Klein A., Kaul I., Foeldvari I., Ganser G. et al. Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry. Arthr. Care Res. (Hoboken). 2012; 64 (9): 1349–1356.
Review
For citations:
Ushakova S.A., Pavlova O.V., Khalidullina O.Yu., Lukyanova V.N. EXPERIENCE OF THE EFFICIENT USING OF METHOTREXATE FOR SUBCUTANEOUS ADMINISTRATION IN PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS. Current Pediatrics. 2014;13(4):150-155. (In Russ.) https://doi.org/10.15690/vsp.v13i4.1101